back to Australia directory
australia clinical guidance

Long-acting reversible contraception (LARC): IUD/IUS, implant, injection

A detailed Australian summary of long-acting reversible contraception (larc): iud/ius, implant, injection, with source-attributed priorities, a practical workflow, safety escalation and state or territory implementation boundaries.

JurisdictionAustralia
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceHealthcare professionals practising in Australia
This is an iatroX educational summary of named Australia sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Apply current TGA product information, PBS restrictions, state or territory law, local referral criteria, formulary and antimicrobial policy. A national recommendation does not create uniform service access.

Scope

Offer implant and intrauterine methods to eligible people as highly effective reversible options without restricting access by age or parity. Choose method through bleeding preference, dysmenorrhoea, uterine anatomy, STI risk, medicines, breast cancer, reproductive coercion and fertility timing. This summary is limited to the population, decisions and escalation boundaries stated in the named source.
sources for this section:RANZCOG contraception

The Bottom Line

  • Offer implant and intrauterine methods to eligible people as highly effective reversible options without restricting access by age or parity.
  • Choose method through bleeding preference, dysmenorrhoea, uterine anatomy, STI risk, medicines, breast cancer, reproductive coercion and fertility timing.
  • Offer STI screening based on exposure without delaying same-day insertion when infection is not clinically suspected.
  • Use trained insertion with consent, pregnancy exclusion, asepsis and current Australian analgesia and infection-screening guidance.
sources for this section:RANZCOG contraception

Practical clinical workflow

1

Topic-specific assessment action

Offer implant and intrauterine methods to eligible people as highly effective reversible options without restricting access by age or parity.
2

Topic-specific diagnostic action

Use trained insertion with consent, pregnancy exclusion, asepsis and current Australian analgesia and infection-screening guidance.
3

Topic-specific management action

Explain expected bleeding, thread or implant checks, expulsion or perforation warning signs, duration and return to fertility and document device details.
4

Topic-specific follow-through

Insertion after birth or abortion has different expulsion, perforation and timing considerations that require the specific pathway.
sources for this section:RANZCOG contraception

Safety boundaries and escalation

  • Severe post-insertion pain, fever, heavy bleeding, pregnancy, missing device with symptoms or suspected perforation requires urgent clinical and imaging assessment.
  • For an implant, interacting enzyme inducers can reduce contraceptive efficacy and require an alternative method.
sources for this section:RANZCOG contraception

Implementation

The named source is national or binational guidance used in Australia, but referral access, public-health directions, formularies and funded services can still differ by state, territory and health service. Check current TGA product information for medicines. Offer culturally safe care and use the NACCHO鈥揜ACGP National Guide where Aboriginal and Torres Strait Islander preventive or chronic-care recommendations differ.
sources for this section:RANZCOG contraception

Clinical use boundary

This independently written summary is not an official guideline. Check the linked source version, current TGA-approved product information where medicines are involved, and the applicable state, territory and local pathway at the point of care.

sources for this section:RANZCOG contraception

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. Royal Australian and New Zealand College of Obstetricians and GynaecologistsContraception (C-Gyn 3)C-Gyn 3 路 Version 7.2, September 2024; review due March 2029 路 accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the Australia question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.